Broadley, KJ. The vascular effects of trace amines and amphetamines Pharmacol. Ther., 1 Mar 2010, 125 (3), 363–375. 1.1 MB. https://doi.org/10.1016/j.pharmthera.2009.11.005 #L-DOPA
Hoffer, A; Osmond, H. The Hallucinogens, Academic Press, New York, . 3.9 MB. #Dihydroxyphenylalanine
Anneken, JH; Angoa-Perez, M; Sati, GC; Crich, D; Kuhn, DM. Assessing the role of dopamine in the differential neurotoxicity patterns of methamphetamine, mephedrone, methcathinone and 4-methylmethamphetamine Neuropharmacology, 1 May 2018, 134, 46–56. 3.5 MB. https://doi.org/10.1016/j.neuropharm.2017.08.033 #L-D
Torrens-Spence, MP; Liu, C; Pluskal, T; Chung, YK; Weng, J. Monoamine biosynthesis via a noncanonical calcium-activatable aromatic amino acid decarboxylase in psilocybin mushroom ACS Chem. Biol., 21 Dec 2018, 13 (12), 3343–3353. 5.9 MB. https://doi.org/10.1021/acschembio.8b00821 #L-DOPA other
Wilson, SM; Wurst, MG; Whatley, MF; Daniels, RN. Classics in chemical neuroscience: Pramipexole ACS Chem. Neurosci., 2 Sep 2020, 11 (17), 2506–2512. 984 kB. https://doi.org/10.1021/acschemneuro.0c00332 #4
Benington, F; Morin, RD; Clark, LC. Mescaline analogs. III. 2,4,6-Trialkyl- and 3,4-dihydroxy-5- methoxy-β-phenethylamines J. Org. Chem., 1 Sep 1955, 20 (9), 1292–1296. 345 kB. https://doi.org/10.1021/jo01126a019 #V